Please assess the completion status of the following clinical trial:

Trial Title: A Study of the Use of Methotrexate in the Treatment of Chronic Idiopathic Urticaria

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* severe unremitting chronic idiopathic urticaria~* disease resistant to treatment with antihistamines~* aged 18 years or more~Exclusion Criteria:~* predominant physical urticaria~* urticarial vasculitis~* any contraindication to the use of methotrexate, eg. pregnancy / breast feeding, women wanting to conceive or man wanting to father a child within 12 months of entry, use of drugs which interact, underlying medical conditions~* use of immunosuppressant within 4 weeks of entry

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 methotrexate (Type: ACTIVE_COMPARATOR): patient to receive methotrexate
- 2 Placebo (Type: PLACEBO_COMPARATOR): given placebo capsules

Based on this trial design, predict the completion outcome and termination type (if applicable).